Ngapas, Rahma M.
HRN: 10-43-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2022
CIPROFLOXACIN 500MG (TAB)
05/24/2022
05/30/2022
PER NGT
500mg
BID
Diabetic Foor
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes